Nordic I-O Mission: Meet 11 Nordic I-O companies in NY


Event Details


This is event is by invitation only. If you would like to receive an invitation, please notify hanne.mette.dyrlie.kristensen@innovasjonnorge.no.

Attendees can use this opportunity to connect to a group of Nordic Immuno-Oncology companies, learn more about their technologies, preclinical and clinical assets, and discuss collaboration opportunities

One-page company descriptions can be downloaded here.

  • Thursday, March 22nd, 12.00-3PM:

Financial/business track, mingling and lunch at the Royal Norwegian Consul’s residence, NY

Program:

  • 12:30      Arrival
  • 12:45      Welcome
  • 12:50      James Cirenza (along with Kristoffer Braaten) – Managing Director, DNB Markets –  Discussion on US Healthcare Equity Markets / IPO’s
  • 1:05 PM Henrik Asland – SVP, DNB Global Cash Management –  Differences between Nordic and US Cash Management
  • 1:20 PM Henrik Asland /Robert Masella – Partner,  Shearman & Sterling LLP, Head of Healthcare Mergers and Acquisitions  – Discussion on Healthcare Collaborations, Licensing, M&A

Senior Executives from the following Nordic companies will be present:

Hosted by the Royal Norwegian Consulate, co-organized with DNB.

Print This Post